top of page
bg_edited_edited.png

The Future of Brain-Computer
Interfaces is Non-Invasive

CHIP.png

Founding Mission

Traditional deep learning paradigms have failed to bring non-invasive neurotechnology to the next level. We believe that the Manhattan Project for non-invasive BCI is inevitable. The potential to revolutionize the safe diagnosis and treatment of all neurological conditions is too great to ignore.

Neuralis™

The first widely available platform to monitor the visual cortex is now in clinical trials for non-invasive wheelchair control. Our unique platform can be used for Alzheimer’s and Autism diagnostics, as well as a powerful tool for neuromarketing.

Current Research

Powerful breakthroughs in deep learning for BCI

Founding Team

Advisors

Abstract Objects

Get in Touch

Designed + Built in New York City

  • X
  • LinkedIn
  • Instagram

Thanks for submitting!

Follow Us On:

  • LinkedIn
  • Instagram
  • Twitter

© 2024 by Synaptrix Labs Inc.

Subscribe to Our Newsletter

Thanks for submitting!

Neuralis is still in development and has not been evaluated by the FDA

bottom of page